We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Small GTPases

Now An Open Access Journal

Submit Your Research

Small GTPases is converting to Open Access from its 2023 volume.

Small GTPases is building on its strong foundation established over 12 years of reporting leading research by transitioning to an Open Access publishing format. The conversion to Open Access will help ensure that research published in Small GTPases will be fully accessible to all interested readers, with no barriers limiting global reach and impact. The market-leading web platform provided by Taylor & Francis, our innovative communications strategy and dedicated communications account will enable publications in Small GTPases to reach the widest possible audience.

Under the direction of the Editor-in-Chief Michael Olson, Professor of Chemistry and Biology at Toronto Metropolitan University and Canada Research Chair in Molecular Cell Biology, and supported by the diverse international editorial board, Small GTPases will continue to be a dedicated forum for the sharing of information at the forefront of the field, covering a broad range of research including cell and in vivo biology, structural studies, biochemistry, and drug discovery. In addition to the GTPase proteins themselves, Small GTPases features research focused on the structure, regulation, and function of their regulators and effectors.

The journal will maintain its notable track record of providing rapid peer review, undertaken by leading researchers from around the world to ensure rigorous evaluation and subsequent publication of high quality and robust research articles. In addition to research articles, Small GTPases will continue to publish timely reviews, mini‐reviews and commentaries that provide background and context for new discoveries. The success of our reviews as foundational in their respective fields is reflected in their high citation rates.

From 29th June, all manuscripts submitted to the journal will, if accepted, be required to pay an article publishing charge (APC) which can be covered by an author’s funder or institution. We look forward to receiving your submissions and welcome your support in this exciting new open access chapter for the journal.

    Contribute to Small GTPases

    To reflect the advances in methodologies used for biological research, Small GTPases is particularly interested in manuscripts that make use of emerging approaches, including systems biology, biophysics, advanced imaging, and bioinformatics. These approaches complement classical experimental techniques to discover the underlying mechanisms that small GTPases employ to regulate fundamental biological processes.

    Small GTPases will also support the creation and publishing of timely Article Collections, composed of a curated group of published articles centred around a theme or topic. Researchers interested in Guest Editing an Article Collection are encouraged to contact the Editor-in-Chief to discuss topics.

                There is a comprehensive description of the journal scope as well as a clear set of instructions for authors on the  journal website.  

                Interested authors should visit the Taylor & Francis  Open Access Members and  Open Access Agreements pages to find out if they are based at an institution that may have funds available to authors wishing to publish in Small GTPases. Interested readers may also want to sign up to receive  latest article alerts to keep up-to-date with the latest research published in the journal. 

                We look forward to receiving your submissions and hope you join us to embrace Small GTPase’s Open Access future. 


                Professor Michael F Olson is a Tier 1 Canada Research Chair in the Department of Chemistry and Biology at Toronto Metropolitan University. After obtaining a PhD in Pharmacology at the University of Toronto in 1993, Prof. Olson worked with Alan Hall at the Medical Research Council Laboratory of Molecular Cell Biology at University College London, and then in 1995 moved to the Chris Marshall laboratory at the Institute of Cancer Research in London UK. A Royal Society University Research Fellowship enabled Prof. Olson to begin his career as an independent principal investigator in 1998 at the Institute of Cancer Research. In 2001, he moved to the University of Pennsylvania to become an Assistant Investigator in the Abramson Family Cancer Research Institute.

                In 2004, Professor Olson returned to the UK, to the Cancer Research UK Beatson Institute in Glasgow Scotland. Upon receiving the Tier 1 Canada Research Chair in 2018, he repatriated to Canada to take up his current position at Toronto Metropolitan University. Professor Olson’s current research focusses on understanding the molecular mechanisms used by the Rho family Small GTPases in the regulation of tumour cell proliferation, apoptosis/survival, and migration. These studies have also contributed to the discovery of novel inhibitors of Rho signalling pathway components.

                Professor Michael Olson

                Why publish open access?

                • Increase the visibility and readership of your research by publishing in a fully open access journal.

                • Make an impact beyond the academy by making your article accessible to anyone, anywhere (including readers in industry and even policy-makers).

                • Freely share your work with no restrictions or paywall.

                • Retain ownership of your research through our unrestrictive publishing agreements.

                • Discounts and waivers for researchers in developing countries are available. The journal will also consider requests for discretionary APC waivers. Find out if your institution or country has an open access agreement to publish with us.

                Read the latest open access research published in the journal.

                Find the latest tweets from @SmallGTPases

                We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.